Sourcing APIs, Generics & OTC from India

 
India undoubtedly is today’s global generics king !

In the US, 80 % of prescriptions use low-cost generics and out of that a whopping 25% comes from INDIA ! Generic drugs helped the US save $ 158 billion USD in 2010.

INDIA ranks 3rd in terms of global pharmaceutical volume production yet 14th in dollar value, i.e. THAT’s HOW COMPETITIVE LOW-COST GENERICS PRODUCTION is in INDIA !



Check out these numbers below—over 35% of Abbreviated New Drug Applications (ANDA) has been filed by Indian pharmaceutical drug manufacturing companies.


 
Generics spending in 2015 is expected to be between $400-430 bill., 70% of which will be outside developed markets
Globally, governments are expected to reduce total drug spending by about $80 - $100 billion through 2014 *** part of the Indian generic bonanza ***!

BUT TO SOURCE FROM INDIA- one needs to understand India – its history, people, culture and Business Best Practices (or Lack thereof !) – therein LIES THE CHALLENGES TO SOURCING from INDIA.

FDASmart understands India well and has been OPERATING FROM INDIA since the mid-1990s when Pfizer commissioned us to create 1 100% Pfizer-owned CLINICAL DATA MANAGEMENT group in Mumbai, India.

Let FDASmart ASSIST YOU TO NAVIGATE SOURCING from India. ASK US HOW !